1
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
Condition(s):Acute GVHDLast Updated:January 18, 2022Recruiting
Prograf: 1578 Clinical Trials, Page 1 of 158
Hide Studies Not Open or Pending
2
Pharmacokinetic Comparison Of All FK-506 Formulations
Condition(s):Renal FailureLast Updated:January 18, 2016Completed
3
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Condition(s):Transplant;Failure,KidneyLast Updated:March 19, 2021Recruiting
4
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
Condition(s):Evidence of Liver Transplantation; Effects of Immunosuppressant TherapyLast Updated:October 12, 2016Completed
5
Envarsus XR in Lung Transplant
Condition(s):Lung TransplantLast Updated:August 30, 2021Recruiting
6
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
Condition(s):Prophylaxis Against Liver Transplant RejectionLast Updated:May 17, 2022Recruiting
7
A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients
Condition(s):Kidney TransplantationLast Updated:November 7, 2018Completed
8
A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year
Condition(s):Liver TransplantationLast Updated:March 26, 2019Completed
9
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Condition(s):Kidney Failure; Renal FailureLast Updated:May 19, 2015Completed
10
OPTImization of the Dose of tacroliMUS by Bayesian Prediction
Condition(s):KIDNEY TRANSPLANTATIONLast Updated:January 8, 2021Completed